Commercializing Living Therapies with CCRM
Duración total:
11 h 30 min
Investing in the future of medicine: Trends, hurdles and opportunities in the CGT sector
Commercializing Living Therapies with CCRM
38:18
Navigating commercialization: Regional hubs, global solutions
Commercializing Living Therapies with CCRM
23:09
Enabling patient access to cell and gene therapies
Commercializing Living Therapies with CCRM
28:20
Unapproved stem cell therapies: Risks, realities and responsibilities
Commercializing Living Therapies with CCRM
35:30
Biomanufacturing redefined: The role of AI and robotics in producing cell and gene therapies
Commercializing Living Therapies with CCRM
34:59
Expert insights for taking a cell or gene therapy company from vision to reality
Commercializing Living Therapies with CCRM
26:25
Regulators' strategies for managing the surge in cell and gene therapies
Commercializing Living Therapies with CCRM
27:35
How Creative Destruction Lab accelerates the advanced therapies industry
Commercializing Living Therapies with CCRM
24:23
The synergy solution: How public-private partnerships advance regenerative medicine
Commercializing Living Therapies with CCRM
34:43
Catalysts of change: Canada’s research hubs are shaping the future of biomanufacturing
Commercializing Living Therapies with CCRM
33:24
From code to cure: Exploring the synergies of artificial intelligence and regenerative medicine
Commercializing Living Therapies with CCRM
33:23
Stuck in the sixties: The fight to fast-forward access to better cancer treatment
Commercializing Living Therapies with CCRM
27:24
CAR T therapies: Engineering immune cells to treat cancer
Commercializing Living Therapies with CCRM
31:10
Protecting the product of innovation: IP and commercialization in cell and gene therapies
Commercializing Living Therapies with CCRM
34:23
Mentoring: making moves to maximize career growth
Commercializing Living Therapies with CCRM
27:53
Unlocking the potential of induced pluripotent stem cells
Commercializing Living Therapies with CCRM
27:31
Training tomorrow’s talent: building the biomanufacturing workforce
Commercializing Living Therapies with CCRM
23:05
You get what you pay for
Commercializing Living Therapies with CCRM
35:21
A busy intersection: Ethics and policy in cell and gene therapies
Commercializing Living Therapies with CCRM
35:25
The Future’s Synthetic
Commercializing Living Therapies with CCRM
25:23
Moving from A to B
Commercializing Living Therapies with CCRM
31:10
Chaperoning innovation through the valley of death
Commercializing Living Therapies with CCRM
26:32
The importance of educating the public about cell and gene therapies
Commercializing Living Therapies with CCRM
24:43
